Brilliant Violet 711a,,cents anti-T-bet [4B10] and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0469412
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $363.00
About this award
The University of Virginia awarded contract A207_PO-0469412 to BioLegend Inc. on August 15, 2026, in the Commonwealth of Virginia. The contract involves the procurement of laboratory reagents, specifically Brilliant Violet 711a anti-T-bet [4B10] monoclonal antibodies. Two units of this flow cytometry reagent were ordered at a unit price of $181.50 each, with delivery directed to Selin Ustel at the University of Virginia.
The total contract value is $363.00. No specific contract performance period or completion date is identified in the award documentation. BioLegend Inc. serves as the prime contractor responsible for supplying the specified immunological research reagents to support the University of Virginia's laboratory operations and research initiatives.
Line items
| Item | Total |
|---|---|
| Brilliant Violet 711a,,cents anti-T-bet [4B10] | $181.50 |
| Brilliant Violet 711a,,cents anti-T-bet [4B10] | $181.50 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0469412?
Contract A207_PO-0469412 was awarded to BIOLEGEND INC. by University of Virginia on August 15, 2026.
How much is contract A207_PO-0469412 worth?
Its cumulative value is $363.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award